Form PREC14A - Preliminary proxy statements, contested solicitations:
SEC Accession No. 0001193805-25-000336
Filing Date
2025-03-21
Accepted
2025-03-21 12:55:01
Documents
4

Document Format Files

Seq Description Document Type Size
1 prec14a14390002_03202025.htm PREC14A 334869
2 GRAPHIC image_001.jpg GRAPHIC 48346
3 GRAPHIC image_002.jpg GRAPHIC 26439
4 GRAPHIC image_003.jpg GRAPHIC 12046
  Complete submission text file 0001193805-25-000336.txt   456469
Mailing Address 8 DAVIS DRIVE SUITE 220 DURHAM NC 27709
Business Address 8 DAVIS DRIVE SUITE 220 DURHAM NC 27709 248-681-9815
Opus Genetics, Inc. (Subject) CIK: 0001228627 (see all company filings)

EIN.: 113516358 | State of Incorp.: DE | Fiscal Year End: 1231
Type: PREC14A | Act: 34 | File No.: 001-34079 | Film No.: 25759808
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address 17199 N. LAUREL PARK DRIVE SUITE 401 LIVONIA MI 48152
Business Address
Sooch Mina (Filed by) CIK: 0001674006 (see all company filings)

Type: PREC14A